Brief: Adial Pharmaceuticals Announces Acquisition Of Azora Therapeutics And Up To $64 Million Financing
11/06/2026 19:16
BRIEF-Adial Pharmaceuticals Announces Acquisition Of Azora Therapeutics And Up To $64 Million Financing June 11 (Reuters) - Adial Pharmaceuticals Inc ADIL.O:
ADIAL PHARMACEUTICALS ANNOUNCES ACQUISITION OF AZORA THERAPEUTICS AND UP TO $64 MILLION FINANCING
ADIAL PHARMACEUTICALS - RECEIVES $32 MILLION UPFRONT FINANCING FOR PRE-FUNDED WARRANTS AT $2.75 EACH
ADIAL PHARMACEUTICALS - ENTERS AGREEMENT FOR UP TO $64 MILLION PRIVATE PLACEMENT
ADIAL PHARMACEUTICALS - POST-DEAL: ADIAL HOLDERS 7.7%, AZORA HOLDERS 51%, INVESTORS 41.3% OF COMMON STOCK
Source text: ID:nGNX2Gr8KF
Further company coverage: ADIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)